Guinea pig airway hyperresponsiveness induced by blockade of the angiotensin II type 1 receptor: Role for endogenous nitric oxide

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 1, 1999, Pages 165-168

  Kanazawa, Hiroshi ^a   Hirata, Kazuto ^a   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ACETYLCHOLINE; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

AIRWAY OBSTRUCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; BRONCHOSPASM; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; GUINEA PIG; MALE; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RESPIRATORY EPITHELIUM;

EID: 0032903994     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.1.9803076     Document Type: Article

References (23)

1. Materson, B. J., and R. A. Preston. 1994. Angiotensin-converting enzyme inhibitors in hypertension. Arch. Intern. Med. 154:513-523.
2. The SOLVD Investigators. 1992. Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N. Engl. J. Med. 327:685-691.
3. Ambrosioni, E., C. Borghi, and B. Magnani. 1995. The effect of the angiotensin-converting enzyme inhibitor zofenopril on mortality and morbidity after anterior myocardial infarction. N. Engl. J. Med. 332: 80-85.
4. Ravid, D., M. Lishner, R. Rang, and M. Ravid. 1994. Angiotensin-converting enzyme inhibitors and cough: a prospective evaluation in hypertension and in congestive heart failure. J. Clin. Pharmacol. 34: 1116-1120.
5. Lacourciere, Y., J. Lefebvre, G. Nakhle, E. P. Faison, D. B. Snavey, and E. B. Nelson. 1994. Association between cough and angiotensin converting inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study. J. Hypertens. 12:S49-S53.
6. Dusser, D. J., J. A. Nadel, K. Sekizawa, P. D. Graf, and D. B. Borson. 1988. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea. J. Pharmacol. Exp. Ther. 244:531-536.
7. Simonsson, B. G., B.-E. Skoogh, N. P. Bergh, R. Andersson, and N. Svedmyr. 1973. In vivo and in vitro effect of bradykinin on bronchial motor tone in normal subjects and patients with airways obstruction. Respiration 30:378-388.
8. Lunde, H., T. Hedner, O. Samuelsson, J. Lotval, L. Andren, L. Lindholm, and B.-E. Wiholm. 1994. Dyspnoea, asthma, and bronchospasm in relation to treatment with angiotensin converting enzyme inhibitors. B.M.J. 308:18-21.
9. Cockcroft, J. R., D. G. Sciberras, M. R. Goldberg, and J. M. Ritter. 1993. Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm. J. Cardiovasc. Pharmacol. 22:579-584.
10. Dicpinigaitis, P. V., S. A. Thomas, M. B. Sherman, Y. E. Gayle, and D. L. Rosenstreich. 1996. Losartan-induced bronchospasm. J. Allergy Clin. Immunol. 98:1128-1130.
11. Acker, C. G., and A. Greenberg. 1995. Angioedema induced by the angiotensin II blocker losartan [letter]. N. Engl. J. Med. 333:1572.
12. Folkerts, G., and F. P. Nijkamp. 1985. Haemophilus influenza induces a potentiated increase in guinea pig pulmonary resistance to histamine. Eur. J. Pharmacol. 119:117-120.
13. Tsukahara, H., D. V. Gordienko, and M. S. Goligorsky. 1993. Continuous monitoring of nitric oxide release from human umblical vein endothelial cells. Biochem. Biophys. Res. Commun. 193:722-729.
14. Nijkamp, F. P., H. J. Vander Linde, and G. Folkerts. 1993. Nitric oxide synthesis inhibitors induce airway hyperresponsiveness in the guinea pig in vivo and in vitro: role of the epithelium. Am. Rev. Respir. Dis. 148:727-734.
15. Folkerts, G., H. J. Van der Linde, and F. P. Nijkamp. 1995. Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J. Clin. Invest. 95:26-30.
16. Kanazawa, H., S. Shoji, K. Hirata, N. Kurihara, and J. Yoshikawa. 1996. Role of endogenous nitric oxide in airflow obstruction in smokers. Chest 110:927-929.
17. Kanazawa, H., T. Kawaguchi, S. Shoji, T. Fujii, S. Kudoh, K. Hirata, N. Kurihara, and J. Yoshikawa. 1997. Synergistic effect of nitric oxide and vasoactive intestinal peptide on bronchoconstriction against histamine in anesthetized guinea pigs. Am. J. Respir. Crit. Care Med. 155: 747-750.
18. Timmermans, P., P. C. Wong, A. T. Chiu, W. F. Herblin, P. Benfield, D. J. Carini, R. J. Lee, R. R. Wexler, J. A. M. Saye, and R. D. Smith. 1993. Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol. Rev. 45:205-250.
19. Entzeroth, M., and S. Hadamovsky. 1991. Angiotensin II receptors in the rat lung are of the AII-1 subtype. Eur. J. Pharmacol. 206:237-241.
20. Liu, Y.-H., X.-P. Yang, V. G. Sharov, O. Nass, H. N. Sabbah, E. Peterson, and O. A. Carretero. 1997. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure: role of kinins and angiotensin II type 2 receptors. J. Clin. Invest. 99:1926-1935.
21. Moncada, S., R. M. Palmer, and E. A. Higgs. 1991. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:109-142.
22. Millar, E. A., R. M. Angus, G. Hulks, J. J. Morton, J. M. C. Connell, and N. C. Thomson. 1994. Activity of the renin-angiotensin system in acute severe asthma and the effect of angiotensin II on lung function. Thorax 49:492-495.
23. Millar, E. A., J. E. Nally, and N. C. Thomson. 1995. Angiotensin II potentiates methacholine-induced bronchoconstriction in human airway both in vitro and in vivo. Eur. Respir. J. 8:1838-1841.